. Adhesion-dependent activation of CaMKII and regulation of ERK activation in vascular smooth muscle.
evidence has been produced indicating spatial organization of signaling intermediates in the ERK activation cascade facilitated by scaffolding proteins and/or scaffolding domains in receptor tyrosine kinases (4, 35) . In cultured VSM cells, we have documented PKC ␦-isozyme and CaMKII pathways that mediate GPCR ligand-dependent activation of ERK1/2 (1, 10, 11) . PKC-␦ and CaMKII-dependent ERK activation in VSM requires activation of nonreceptor tyrosine kinases (Src family kinases and Pyk2) and transactivation of epidermal growth factor receptors (EGFRs) (10, 11) .
Cell adhesion to extracellular matrix proteins such as fibronectin and collagen is mediated by the binding of integrin receptors to ECM ligands (13) . Integrin engagement leads to a number of intracellular signaling events, including the activation of Src family kinases (SFKs) and ERK1/2, responses that are dependent on the tyrosine phosphorylation (Tyr 397 ) and activation of focal adhesion kinase (FAK) (20) . A potential mechanism for integrin-dependent activation of ERK1/2 involves the scaffolding protein paxillin, which is activated by binding to FAK and Src-dependent tyrosine phosphorylation upon integrin clustering (4, 12) . Activated paxillin binds Raf, MEK, and ERK, thereby facilitating ERK activation and localization in focal adhesions (4, 37) . The importance of paxillin in promoting adhesion-dependent ERK1/2 activation has been indicated in studies documenting diminished adhesion-dependent ERK activation in paxillin-knockout cells (12) . FAK, SFKs, paxillin, and ERK1/2 are key regulators of focal adhesion dynamics and therefore are important in regulating cell adhesion and migration (22, 37) .
Intracellular Ca 2ϩ signals can also initiate events that are important in regulating VSM cell migration (28, 33) . One possible mechanism is disassembly of focal adhesions at the trailing edge of migrating cells in response to localized transient increases in free intracellular Ca 2ϩ (9) . A combination of cell adhesion and serum or growth factor stimulation has reported to increase the frequency of cultured VSM cell Ca 2ϩ transients as well as the rate of migration (28) . Integrin signaling may play a role in regulating intracellular Ca 2ϩ (31, 38) . It has been reported that ligand binding of integrin receptors triggered Ca 2ϩ influx and inositol 1,4,5-trisphosphate (IP 3 )-dependent intracellular Ca 2ϩ release in Madin-Darby canine kidney epithelial cells (31) . In differentiated contractile VSM cells, integrin ␣ v ␤ 3 and ␣ 5 ␤ 1 differentially regulate L-type Ca 2ϩ channels, which is related to Ca 2ϩ influx leading to muscle contraction (38) . Conversely, CaM-dependent activation of calcineurin and CaMKII has been reported to regulate integrin binding affinity (3) . Several studies have implicated CaMKII as a mediator of Ca 2ϩ -dependent regulation of VSM cell migration (2, 18, 23, 24) , although the targets and mechanisms of regulation are not yet clear. In a recent study in which the researchers used an immortalized thyroid cell line (TAD-2) and Hep3B cells, adhesion to fibronectin was found to activate ERK1/2 by a CaMKII-and Raf-dependent mechanism (14) .
In the present study, we first tested the hypothesis that CaMKII is activated upon VSM cell adhesion and determined the role of integrin-dependent signaling pathways involving FAK activation in that process. The studies indicated that VSM cell adhesion results in rapid activation of CaMKII by a mechanism that does not require integrin signaling or FAK activation. Second, using both pharmacological and molecular approaches, we tested the function of CaMKII in modulating adhesion-dependent signaling events that result in ERK1/2 activation. Adhesion-dependent activation of CaMKII does not affect FAK activation but does facilitate FAK-dependent tyrosine phosphorylation of paxillin and ERK1/2 activation. Overall, the results suggest that adhesion-dependent activation of CaMKII and FAK are independent events and that CaMKII facilitates ERK1/2 activation through both integrin-dependent and integrin-independent mechanisms. CaMKII-dependent regulation of paxillin and ERK1/2 activation is a potential mechanism affecting focal adhesion dynamics.
METHODS
Cell culture. VSM cells were obtained from the medial layer of the thoracic aortas of 200-to 300-g Sprague-Dawley rats as described previously (8) . After removal of the adventitial and endothelial layers, the medial VSM cells were enzymatically dispersed and cultured in DMEM-Ham's F-12 medium with 10% fetal bovine serum (FBS). The VSM cells were maintained at 37°C in a 5% CO 2 atmosphere and split twice weekly. The cells from passages 3-10 were used for experiments. The use of experimental animals for these procedures was reviewed and approved by the Albany Medical College Institutional Care and Use Committee.
SiRNA targeting CaMKII ␦-isoforms and adenovirus construction. The siRNA Target Finder and Design Tool (Ambion, Austin, TX) was used to select specific sequences targeting the rat CaMKII ␦-isoforms (GenBank accession no. NM_12519). Potential small interfering RNA (siRNA) targets were subjected to BLAST searches against expressed sequence tag libraries to confirm specificity and multispecies identity. Target sequences were used to generate adenoviruses expressing short hairpin RNA (shRNA) targeting the CaMKII ␦-subunit, the principal isoform expressed in cultured VSM cells (29) . The sequence targeting all CaMKII ␦-isoforms used in the present study was 5Ј-AAGACAT-AGTGGCAAGAGAAT-3Ј, nt 521-541, and is referred to as siDELTA.
To obtain high efficiency of silencing in these cells, adenoviruses expressing shRNA were produced using the pSuppressorAdeno system (IMG-1200; Imgenex, San Diego, CA). Oligonucleotides were purchased from Integrated DNA Technologies (IDT, Coralville, IA). The sense strand for siDELTA was 5Ј-TCGAGACATAGTGGCAA-GAGAATATATCGATATATTCTCTTGCCACTATGTC-3, and the antisense strand was 5Ј-CTAGGACATAGTGGCAAGAGAATAT-ATCGATATATTCTCTTGCCACTATGTC-3Ј. The underlined nucleotides represent the loop sequence. Annealed DNA was ligated into the linearized pSuppressorAdeno "shuttle" vector and then transformed into competent DH5-␣ cells and selected for ampicillin resistance. Colonies were amplified, and plasmid DNA was purified and sequenced using primers complementary to the pSuppressorAdeno vector to verify the integrity of the shRNA construct. Shuttle plasmids containing siDELTA and small interfering green fluorescent protein (siGFP) (Imgenex) inserts were linearized using Pac1 digestion and cotransfected with linearized pacAd5 plasmid DNA into human embryonic kidney (HEK)-293 cells using Ca 2ϩ -phosphate precipitation. After 10 days and the appearance of viral foci, cells and media were harvested, freeze-thawed three times, and centrifuged, and the supernatant was collected for viral amplification.
Lysates from HEK-293 cells infected with primary viral isolates for 36 h were collected, and the amplified virus was purified by performing CsCl centrifugation. The viral band was purified on a P-10 column (Amersham, Piscataway, NJ) eluted with 2.0 ml of viral preservation medium. To determine the particle-to-infectious unit (PFU) ratio, the virus was serially diluted and applied to HEK-293 cells. After a 3-day infection, viable cells were determined by the incorporation of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT; Sigma, St. Louis, MO). The calculated PFU for each purified virus was 1.9 ϫ 10 10 for siDELTA and 2.5 ϫ 10 10 for siGFP. The purified virus was stored in 10-l aliquots at Ϫ80°C.
Adenoviral infection. VSM cells at ϳ70% confluence were infected with purified adenovirus (Ad)/CaMKII siRNA or Ad/GFP siRNA in the presence of 10% FBS medium. After infection (72-96 h), cells were used for experiments. In other experiments, VSM cells at 70% confluence were infected using Ad/Flag-tagged FRNK. The same multiplicity of infection (MOI) of Ad/␤-galactosidase (Ad/␤-gal) was used for virus controls. After infection (48 h) in the presence of 10% FBS medium, cells were used for experiments. Ad/Flag-tagged FRNK and Ad/␤-gal were provided by Dr. Rebecca S. Keller (Albany Medical College, Albany, NY).
Adhesion assay. VSM cells grown in 10% FBS medium were used in the experiments. At confluence, cells were trypsinized and suspended in 0.4% FBS medium for 30 min. Either suspended cells (n ϭ 500,000) in 0.5 ml of 0.4% FBS medium were replated onto fibronectin (Sigma)-coated 24-well dishes (10 g/ml), or 100,000 suspended cells in 1 ml of 0.4% FBS medium were plated into six wells precoated with poly-L-lysine (Becton Dickinson, Bedford, MA). After defined periods of time, the medium was removed and 1ϫ SDS sample buffer (10% glycerol, 1% SDS, 100 mM Tris, 5% 2-mercaptoethanol, and 0.1% bromphenol blue, pH 7.6) was added to the wells containing the adhering cells, and cells were collected using a cell scraper. The same number of suspended cells were used as a negative control. To test adhesion-dependent CaMKII activation and autophosphorylation on Thr 287 , both suspended and adhering cells were treated with the Ca 2ϩ ionophore ionomycin (Calbiochem, La Jolla, CA) at 0.5 M concentration for 30 s as a positive control to determine the maximal activation responses. To collect protein in suspended cells, equal volumes of 20% ice-cold trichloroacetic acid were added, incubated for 30 min at 4°C and then centrifuged at 14,000 g at 4°C for 1 min. The pellet was washed with acetone three times, dried in the air, and then dissolved in 100 l of 1ϫ SDS sample buffer and sonicated at 22°C for 30 min.
Western blot analysis. Samples were heated at 95°C for 5 min and centrifuged at 14,000 g for 2 min at 22°C. Proteins were resolved by SDS-PAGE and transferred electrophoretically to a nitrocellulose membrane. Blots were blocked in 5% nonfat milk-Tris-buffered saline with Tween 20 (TBST) for 30 min at 22°C, incubated with recommended dilutions of primary antibody in TBST for 1 h at 22°C, and washed three times with TBST. The blots were then incubated with horseradish peroxidase (HRP)-conjugated secondary antibody in TBST for 1 h at 22°C and washed three times with TBST before detection using a commercial chemiluminescence kit (Amersham) and exposure to X-ray film.
Antibodies. Anti-phospho-CaMKII (Thr 287 ) and anti-CaMKII ␦2-isoform antibodies were produced as previously described (29, 34 
RESULTS

CaMKII is activated upon VSM cell adhesion. Previous studies indicated that in VSM cells, CaMKII functions as an intermediate for Ca
2ϩ -induced ERK1/2 activation through transactivation of EGFRs (1, 10, 11) . In those studies, a GPCR agonist or the Ca 2ϩ ionophore ionomycin was used to stimulate increases in free intracellular Ca 2ϩ and activation of CaMKII. Adhesion of VSM cells to multiple substrates has also been reported to stimulate intracellular Ca 2ϩ transients (28), and adhesion-dependent activation of ERK1/2 has been described in a number of systems (7, 20, 37) . To determine whether CaMKII was activated in response to VSM cell adhesion, cultured cells were enzymatically dispersed and replated on fibronectin (10 g/ml)-coated plates after 30-min suspension in 0.4% FBS medium. CaMKII activation was assessed by performing Western blot analysis using a specific antibody for the kinase autophosphorylated on Thr 287 (34) . Autophosphorylation at this site is dependent on activation of subunits by CaM (25) . CaMKII autophosphorylation was stimulated within 25 min after cell adhesion to fibronectin compared with unstimulated suspended cells, although the addition of ionomycin further increased activation levels ( To assess CaMKII activation at early time points after plating but before adhesion was complete, autophosphorylation signals were normalized against recovered CaMKII protein and then compared with the normalized signal from unstimulated suspended cells. CaMKII activation was maximally increased fourfold by ionomycin stimulation in both suspended and adhering cells (Fig. 1B) . CaMKII activation in response to adhesion alone was ϳ75% of maximal ionomycin-induced activation, or about threefold that of control levels. Using this analysis, CaMKII activation could be detected in VSM cells as early as 1 min after being replated on fibronectin-coated dishes.
In addition to fibronectin, CaMKII activation was observed to occur rapidly upon cell adhesion to multiple substrates, including collagen, laminin, and fibrinogen (data not shown). However, the addition of solubilized fibronectin to suspended cells failed to activate CaMKII (Fig. 1C) , suggesting that integrin binding alone was insufficient to trigger the response.
Adhesion-dependent CaMKII activation is independent of integrin signaling. Activation of FAK by tyrosine phosphorylation after integrin engagement causes recruitment of adhesion molecules such as paxillin, talin, and vinculin to form a focal adhesion complex (20, 37) . To determine whether the signal for CaMKII activation was dependent on FAK activation, FRNK, an endogenous inhibitor of FAK (27, 32) , was overexpressed in VSM cells. FRNK is a COOH-terminal fragment of FAK that inhibits phosphorylation of FAK on Tyr 397 and interferes with FAK protein-protein interactions (26) . As expected, adhesion-dependent tyrosine phosphorylation and activation of FAK and paxillin was inhibited by the overexpression of FRNK introduced by adenoviral infection (Fig. 2A) . In contrast, under these conditions of FRNK overexpression, adhesion-dependent activation of CaMKII was unaffected (Fig.  2B ), indicating that CaMKII activation is not dependent on prior activation of FAK.
To determine whether adhesion-dependent CaMKII activation was dependent on integrin signaling by pathways other than FAK activation, cells were plated onto poly-L-lysinecoated dishes. While poly-L-lysine promotes VSM cell adhesion, the cell-substrate interactions are thought to be based on charge interactions and the substrate is commonly used as a negative control for integrin-dependent adhesion and signaling (21) . Although FAK and paxillin were slowly activated after adhesion to poly-L-lysine, CaMKII was rapidly and robustly activated, temporally preceding FAK activation (Fig. 3) . Similar to the results in cells adhering to fibronectin, FRNK overexpression did not inhibit activation of CaMKII in cells plated onto poly-L-lysine-coated dishes (data not shown). Taken together, these data strongly suggest that CaMKII activation upon cell adhesion is mediated by an integrin-independent pathway.
CaMKII promotes adhesion-dependent ERK activation. A number of previous studies have documented adhesion-dependent activation of ERK1/2 and implicated this response in the modulation of focal adhesion dynamics (35) . Consistent with these earlier reports, ERK1/2 activation was found to be progressively activated upon VSM cell adhesion to fibronectin (Fig. 4A) . FRNK overexpression blocked activation of ERK1/2 in cells plated onto fibronectin-coated dishes, indicating a key role for FAK activation in that process (Fig. 4) .
To determine whether CaMKII mediated or modulated adhesion-dependent activation of ERK1/2, both molecular and pharmacological approaches were used to suppress CaMKII. In the molecular approach, siRNA (6) was used to suppress CaMKII-␦ expression, the principal CaMKII gene product expressed in these cells (29) . SiRNA target sequences were identified and characterized in preliminary experiments with the use of transient transfection approaches. Two candidate sequences were then cloned as shRNA and introduced into VSM cells using adenoviral vectors (39) . Infection of VSM cells with adenovirus containing shRNA targeting the CaMKII-␦ gene (Ad/siDELTA) resulted in dose (i.e., MOI)-dependent decreases in CaMKII-␦ protein expression levels compared with cells infected with control adenovirus targeting GFP (data not shown). The addition of 150 MOI of Ad/siDELTA resulted in a 59 Ϯ 4% (n ϭ 11) decrease in CaMKII-␦ protein (Fig. 5A) . ERK1/2 activation in response to the addition of iomomycin was inhibited in cells with reduced levels of CaMKII, while phorbol 12,13-dibutyrate (PDBu)-stimulated ERK1/2 activation was unaffected (Fig. 5, A and B) . Similar results were obtained after CaMKII-␦ gene silencing using an alternative target sequence directed against the COOH terminus of CaMKII-␦ 2 (data not shown). Together these data suggest that Ad/siDELTA infection specifically affects Ca 2ϩ -and CaMKIIdependent, but not PKC-dependent, pathways, resulting in ERK1/2 activation.
After suppression of CaMKII-␦ expression with 150 MOI Ad/siDELTA, VSM cells were suspended and replated onto fibronectin-coated dishes to assess adhesion-dependent events.
Adhesion-dependent increases in ERK1/2 activation between 25 min and 2 h were significantly inhibited after suppression of CaMKII-␦ expression (Fig. 6, A and B) . As an alternative approach, addition of KN-93, which selectively inhibits CaMdependent activation of CaMKII (1), inhibited adhesion-dependent activation of ERK1/2 (Fig. 7A) . These data indicate a positive role for CaMKII in modulating adhesion-dependent activation of ERK1/2.
CaMKII modulates adhesion-dependent signaling downstream of FAK activation. Although CaMKII activation is not dependent on prior activation of FAK (Fig. 4) , it facilitated adhesion-dependent signaling, leading to ERK1/2 activation (Figs. 6 and 7) . To determine whether CaMKII promotes ERK activation through modulation of FAK, adhesion-dependent FAK activation was assessed in cells after CaMKII-␦ gene silencing (Fig. 6A) or CaMKII inhibition with KN-93 (Fig.  7B) . Inhibition of CaMKII using either approach had no significant effects on adhesion-stimulated FAK activation (n ϭ 3). Interestingly, tyrosine phosphorylation of paxillin, a re- sponse known to be regulated by the nonreceptor tyrosine kinases FAK and Src (4, 37), was consistently inhibited (31 Ϯ 7%; n ϭ 3 at 2 h) after CaMKII protein suppression with siDELTA compared with siGFP control (Fig. 6A) or inhibition of CaMKII activation with KN-93 (Fig. 7B) . These data suggest that facilitation of adhesion-dependent signaling events resulting in ERK1/2 activation by CaMKII occurs at steps downstream from FAK activation but proximal to paxillin activation.
CaMKII mediates integrin-independent ERK1/2 activation.
Having demonstrated that CaMKII promoted FAK-dependent ERK1/2 activation in cells plated on fibronectin (Figs. 6 and 7) , we tested the role of CaMKII in mediating adhesion-stimulated ERK1/2 activation by an integrin-independent pathway in cells plated onto poly-L-lysine-coated dishes. Suppression of CaMKII expression using siDELTA inhibited ERK1/2 activation at all time points after adhesion onto poly-L-lysine-coated plates (Fig. 8) . Together, these data indicate that CaMKII facilitates adhesion-dependent ERK1/2 activation by both integrin-dependent and integrin-independent mechanisms.
DISCUSSION
CaMKII-dependent activation of ERK1/2 has been described previously in VSM cells (10, 11) and other cells (16) in response to activation by GPCR agonists, depolarizing stimuli, or ionophores that result in increased free intracellular Ca 2ϩ levels. Integrin-mediated cell adhesion has been reported to result in the activation and localization of ERK1/2 in newly forming focal adhesions (7). ERK1/2 activation under these conditions, or under similar conditions in the leading edge of migrating cells, is likely to be important in regulating focal adhesion dynamics (37) and cytoskeletal interactions (15) . These cellular processes are important components of pathophysiological conditions such as restenosis or atherosclerosis, which involve VSM cell proliferative and migratory responses. A number of mechanisms for integrin coupling to ERK activation have been described, including FAK and Src-dependent pathways (7), EGFR transactivation (11) , and caveolin/Fyndependent pathways (36) . In the present study, ERK1/2 activation after VSM cell adhesion was found to be dependent largely on FAK activity as indicated by the inhibition of ERK activation after overexpressing the FAK inhibitor FRNK (Fig.  4) . However, our studies have also revealed additional pathways facilitating adhesion-dependent ERK activation that results from the activation of the multifunctional serine/threonine kinase CaMKII.
Upon activation by CaM binding, CaMKII undergoes rapid autophosphorylation on a specific threonine residue (Thr 287 in the ␦ 2 -subunit) that confers CaM-independent or autonomous activity to the kinase. In the present study, we assessed the phosphorylation of Thr 287 in CaMKII-␦ 2 , the principal isoform expressed in these cells (29) , by performing Western blot analysis using a phospho-peptide-specific antibody as an indicator of CaMKII activation. Adhesion-dependent responses were compared with positive control responses in suspended cells or adhering cells maximally activated with the Ca 2ϩ -ionophore ionomycin. Additional experiments (not shown) confirmed that Thr 287 phosphorylation under these conditions correlated with an increase in autonomous CaMKII activity. Using these approaches, we detected rapid increases in CaMKII activation (within 1 min) in response to the adhesion of VSM cells on fibronectin-coated plates. Similar levels of CaMKII activation upon adhesion to collagen and laminin were observed, suggesting that CaMKII activation is substrate independent.
In the present study, we found no direct evidence for CaMKII activation after the addition of soluble fibronectin to suspended cells. However, adhesion-dependent CaMKII activation in VSM cells was not inhibited by FRNK overexpression and therefore appears to be independent of FAK activity and focal adhesion formation per se. The results of experiments in which we used cells plated onto poly-L-lysine-coated dishes indicate that CaMKII activation after adhesion is not dependent on integrin signaling. These results, along with the rapid kinetics of CaMKII activation that precede activation of FAK and paxillin, suggest that CaMKII activation is triggered by an adhesion-dependent but integrin signaling-independent mechanism in parallel with integrin-dependent FAK activation (summarized in Fig. 9 ). The integrin-independent mechanisms underlying the activation of CaMKII in response to cell adhesion are not known. However, spontaneous Ca 2ϩ transients in VSM cells plated onto poly-L-lysine-coated dishes have a precedent (28) , and at least one potential integrin-independent pathway has been reported for Ca 2ϩ release involving CD44 cell surface receptors for hyaluronan and the cytoskeletal protein ankyrin to form a CD44-ankyrin-sarcoplasmic reticulum IP 3 receptor protein complex (30) .
Regardless of the precise mechanisms, the present studies indicate that adhesion-dependent activation of CaMKII facilitates FAK-dependent tyrosine phosphorylation of paxillin and ERK1/2 activation and also facilitates ERK activation by integrin-and FAK signaling-independent pathways (summarized in Fig. 9 ). Previous studies implicating CaMKII in the regulation of ERK1/2 signaling have relied heavily on pharmacological approaches (1, 11) or overexpression of mutant CaMKII subunits (10) . In the present study, the gene silencing approach using siRNA to suppress expression of endogenous CaMKII-␦ expression in VSM cells provided a strong molecular confirmation of the importance of this multifunctional kinase in regulating ERK1/2 activation by Ca 2ϩ -mobilizing stimuli and by cell adhesion. A role for CaMKII in mediating adhesion-dependent activation ERK also was recently reported in a human thyroid cell line (TAD-2 cells) and in Hep3B (14) . On the basis of those previous studies and the present study using primary cultures of VSM, it seems that adhesion-dependent activation of CaMKII and subsequent ERK1/2 activation may be of importance in diverse cell types.
In the published studies using TAD-2 and Hep3B cells, activation of ERK in response to adhesion to fibronectin was proposed to occur via a mechanism involving the formation of a CaMKII/Raf-1 complex, leading to phosphorylation and activation of Raf-1 by CaMKII and subsequent ERK signaling (14) . However, it was not clearly determined in those studies whether CaMKII directly interacted with and regulated Raf-1 activity or whether the interaction and regulation were indirect and involved intermediary proteins. In the present study, we have shown that gene silencing of CaMKII-␦ or CaMKII inhibition with KN-93 inhibited adhesion-dependent paxillin tyrosine phosphorylation and ERK1/2 activation. Because FAK autophosphorylation on Tyr 397 was unaffected by these treatments and paxillin tyrosine phosphorylation is FAK and Src dependent, we propose that CaMKII acts by facilitating the recruitment of focal adhesion molecules after FAK activation. Tyrosine-phosphorylated paxillin may promote ERK activation by scaffolding proximal elements in the cascade such as Raf and MEK (4) . Such a mechanism would be consistent with CaMKII-dependent Raf activation and CaMKII-Raf protein interactions (14) via the formation of a larger signaling complex. Our experiments using poly-L-lysine as a substrate suggest that in addition to facilitating FAK-dependent paxillin and ERK1/2 activation, CaMKII may also promote ERK1/2 activation via an integrin-independent pathway. Assessment of the relative contribution of this mode of adhesion-dependent ERK1/2 activation in cells adhering to various substrates requires further studies.
FAK, paxillin, and ERK have all been shown to be critical in the regulation of focal adhesion dynamics in migrating cells (37) . A number of studies have also indicated that CaMKII modulates VSM cell migration, demonstrated by the changes in cell migration with the use of pharmacological inhibitors of CaMKII, KN-93 and 1-[N,O-bis-(5-isoquinolinesulfonyl)-Nmethyl-L-tyrosyl]-4-phenylpiperazine (KN-62), respectively (18, 23) , or by overexpressing CaMKII-␦ 2 mutants (constitutively active and kinase negative) to manipulate CaMKII activities (24) . At the cellular level, CaMKII-␦ 2 has been found to be enriched in the pseudopodia of migrating cells (17) . Additional studies, under conditions in which cells that are stimulated to migrate are required to evaluate more carefully a possible role for CaMKII in regulating VSM cell focal adhesion dynamics.
In summary, we have demonstrated that in VSM cells, CaMKII is activated in response to cell adhesion but that, in contrast to many other signaling molecules, this response is rapid and does not require integrin-dependent FAK activation. One function of adhesion-dependent CaMKII activation in VSM cells is to modulate FAK-dependent and FAK-independent ERK1/2 activation. On the basis of previous studies documenting the importance of ERK1/2 in regulating focal adhesion dynamics, the present results provide insight into potential mechanisms by which this multifunctional serine/ threonine kinase could modulate VSM cell migration. Fig. 9 . Proposed model for modulation of adhesion-dependent ERK1/2 activation by CaMKII. CaMKII is rapidly activated upon VSM cell adhesion by an integrin signaling-independent mechanism, because CaMKII activation preceded FAK activation, was unaffected by FAK inhibition with FRNK, and occurred after integrin-independent adhesion to a poly-L-lysine-coated dish. Activation of CaMKII regulates ERK1/2 signaling through both FAK-dependent and FAK-independent mechanisms. Regulation of FAK-dependent tyrosine phosphorylation of paxillin and ERK1/2 activation by CaMKII occurs at a step distal to FAK autophosphorylation and activation.
